| Stage | CAT | % of rev | MTW | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $20.7B | 100.00% | $595M | 100.00% | CAT ×34.77 |
| Gross profit | $7.3B | 35.54% | $123M | 20.69% | CAT +14.8pp |
| Operating income | $4.2B | 20.38% | $31M | 5.23% | CAT +15.1pp |
| Pre-tax income | $4.2B | 20.40% | $21M | 3.60% | CAT +16.8pp |
| Net income | $3.3B | 15.89% | $14M | 2.39% | CAT +13.5pp |
| Stage | CAT | MTW | Gap · A − B |
|---|---|---|---|
| Revenue | $20.7B100.00% | $595M100.00% | CAT ×34.77 |
| Gross profit | 35.54%$7.3B | 20.69%$123M | CAT +14.8pp |
| Operating income | 20.38%$4.2B | 5.23%$31M | CAT +15.1pp |
| Pre-tax income | 20.40%$4.2B | 3.60%$21M | CAT +16.8pp |
| Net income | 15.89%$3.3B | 2.39%$14M | CAT +13.5pp |
No disclosed counterparties: MTW.
None